Skip to main content
Clinical Trials/DRKS00024360
DRKS00024360
Recruiting
未知

In vivo evaluation of molecular tissue properties of enthesial structures using multispectral optoacoustic tomography (MSOT) and arthrosonography in patients with inflammatory joint diseases (psoriasis, psoriatic arthritis) (MAPSA). - MAPSA

niversitätsklinikum Erlangen0 sites90 target enrollmentFebruary 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
L40
Sponsor
niversitätsklinikum Erlangen
Enrollment
90
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Erlangen

Eligibility Criteria

Inclusion Criteria

  • Adult male or female patients capable of giving consent
  • \- Age 18 \- 80 years
  • \- Present informed consent to participate in the study.
  • \- Group 1 PsA
  • o Diagnosis of PsO (clinical and/or histological)
  • o Diagnosis of PsA according to CASPAR criteria
  • \- Group 2 PsO
  • o Diagnosis of PsO (clinical and/or histological)

Exclusion Criteria

  • \- Pregnancy
  • \- Heavy physical activity
  • \- Other previous musculoskeletal disease (such as rheumatoid arthritis, osteoarthritis)
  • \- Tumor disease, diabetes mellitus, cardiovascular disease, chronic kidney, gastrointestinal, or liver disease
  • \- Group 1 PsA
  • o Pre\-treatment or ongoing therapy with bDMARD and/or tsDMARD.
  • \- Group 2 PsO
  • o Diagnosis/family history of rheumatic disease.
  • o tendon pain, joint swelling
  • o Pre\-treatment or ongoing therapy with bDMARD and/or tsDMARD.

Outcomes

Primary Outcomes

Not specified

Similar Trials